Elias Iosifidis - Infectious Diseases

Author Information

Elias Iosifidis is a notable figure in the field of Infectious Diseases, currently affiliated with the Infectious Diseases Unit at the 3rd Department of Pediatrics, Faculty of Medicine, Aristotle University School of Health Sciences, located in Thessaloniki, Greece. He has contributed significantly to pediatric infectious disease research, focusing on various pressing issues such as antimicrobial resistance and viral infections.

Research Contributions

Elias Iosifidis has made substantial contributions to the understanding of infectious diseases, particularly in the pediatric population. His research encompasses a wide array of topics, including the decolonization of carbapenem-resistant bacteria in children, trends in antimicrobial resistance, and the epidemiology of respiratory infections. His work has also explored the implications of antimicrobial stewardship and the value of open-source clinical science in pandemic response. Through his studies, he has provided valuable insights into the challenges of managing infectious diseases in hospital settings, particularly with emerging resistant pathogens.

Aliases

Elias Iosifidis is also known by the aliases E Iosifidis and E. Iosifidis, which are used interchangeably in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers	98
Total Citations	2183
H-index	26

Publications:

A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients.

DOI: 10.1097/INF.0000000000003562

Year: 2022

Changes in molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in the intensive care units of a Greek hospital, 2018-2021.

DOI: 10.1556/030.2022.01715

Year: 2022

Early initiation of the respiratory syncytial virus season in 2021-2022, Greece.

DOI: 10.1002/jmv.27671

Year: 2022

Antimicrobial Stewardship in Pediatric Intensive Care Unit

DOI:

Year: 2021

The value of open-source clinical science in pandemic response: lessons from ISARIC

DOI: 10.1016/S1473-3099(21)00565-X

Year: 2021

SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study

DOI: 10.1017/S0950268821000455

Year: 2021

Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study

DOI: 10.1136/bmjresp-2021-000887

Year: 2021

1162. Antifungal Use in Immunocompromised Children in Europe: a 12-week Multicenter Modified Point prevalence Study (CALYPSO)

DOI: 10.1093/ofid/ofab466.1355

Year: 2021

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

DOI: 10.1007/s15010-021-01599-5

Year: 2021

Emergence of ST39 carbapenem-resistant Klebsiella pneumoniae producing VIM-1 and KPC-2.

DOI: 10.1016/j.micpath.2021.105373

Year: 2021

How is Plasmodium falciparum transmitted?

How is Hepatitis B Transmitted?

What are the Challenges in Malaria Control?

How Does Direct Contact Transmission Occur?

What is the World Health Organization (WHO)?

What Factors Influence Prevalence?

Is There a Vaccine for Ebola?

Why are Serological Tests Important?

What is Nucleic Acid Testing?

What are the advantages of DAAs?

Partnered Content Networks

Relevant Topics